Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Etoposide | 1 | 2018 | 638 | 0.560 |
Why?
|
| Intubation, Intratracheal | 2 | 2024 | 1359 | 0.550 |
Why?
|
| Standard of Care | 1 | 2018 | 569 | 0.460 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 497 | 0.430 |
Why?
|
| Cisplatin | 1 | 2018 | 1656 | 0.400 |
Why?
|
| Testicular Neoplasms | 1 | 2018 | 806 | 0.400 |
Why?
|
| Critical Care | 1 | 2021 | 2714 | 0.300 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 418 | 0.180 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2021 | 132 | 0.170 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15831 | 0.160 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11876 | 0.140 |
Why?
|
| Bleomycin | 1 | 2018 | 492 | 0.140 |
Why?
|
| Laryngoscopy | 1 | 2021 | 714 | 0.130 |
Why?
|
| Professional Practice | 1 | 2016 | 314 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2018 | 846 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1536 | 0.090 |
Why?
|
| Mastectomy | 1 | 2019 | 1861 | 0.090 |
Why?
|
| Amyloidosis | 1 | 2017 | 877 | 0.080 |
Why?
|
| Patient Selection | 1 | 2021 | 4252 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2233 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4892 | 0.070 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 1134 | 0.070 |
Why?
|
| Emergency Medicine | 1 | 2016 | 1220 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10745 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2021 | 65286 | 0.060 |
Why?
|
| Survival Rate | 1 | 2018 | 12826 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 2418 | 0.060 |
Why?
|
| Incidence | 1 | 2021 | 21527 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7073 | 0.050 |
Why?
|
| Masks | 1 | 2024 | 212 | 0.050 |
Why?
|
| Pediatrics | 1 | 2016 | 3614 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 59548 | 0.040 |
Why?
|
| Quality of Life | 1 | 2018 | 13476 | 0.030 |
Why?
|
| Aged | 4 | 2024 | 171344 | 0.030 |
Why?
|
| Male | 4 | 2024 | 364154 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 81657 | 0.030 |
Why?
|
| Middle Aged | 4 | 2024 | 223267 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 1159 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2024 | 1516 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2019 | 1788 | 0.030 |
Why?
|
| Oxygen | 1 | 2024 | 4252 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21162 | 0.020 |
Why?
|
| Critical Illness | 1 | 2024 | 2750 | 0.020 |
Why?
|
| Humans | 6 | 2024 | 766812 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2252 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3552 | 0.020 |
Why?
|
| Breast | 1 | 2019 | 1972 | 0.020 |
Why?
|
| Female | 4 | 2024 | 396532 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6779 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7841 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7430 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4880 | 0.010 |
Why?
|
| Adult | 2 | 2024 | 223305 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29959 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 41706 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 74889 | 0.010 |
Why?
|
| United States | 1 | 2016 | 72945 | 0.000 |
Why?
|
Concepts
(57)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_